4.6 Review

Biomarkers and non-invasive tests for gastrointestinal mucositis

Journal

SUPPORTIVE CARE IN CANCER
Volume 25, Issue 9, Pages 2933-2941

Publisher

SPRINGER
DOI: 10.1007/s00520-017-3752-2

Keywords

Gastrointestinal mucositis; Biomarkers; Citrulline

Funding

  1. Dutch Cancer Society [RUG 2011-5272]

Ask authors/readers for more resources

Gastrointestinal mucositis is a complex inflammatory reaction of the mucous membranes, a side effect of both chemotherapy and radiotherapy. Currently, assessment scales are used to diagnose mucositis. However, a biomarker which would determine whether there is mucositis and thereby establish the severity objectively would be very useful. This will give the opportunity to evaluate studies, to determine risk factors and incidence, and it will make it possible to compare studies. Moreover, this biomarker might improve clinical management for patients. In this paper, we reviewed studies concerning potential biomarkers in blood samples and fecal samples, and potential tests in breath samples and urine samples. We include biomarkers and tests studied in animal models and/or in clinical trials, and discuss the validity, diagnostic accuracy, and applicability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available